Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
Price:
29.78 USD
-2.36%
Market Closed
Updated:
May 20, 2024
Arcturus Therapeutics Holdings Inc
Total Assets
|
Arcturus Therapeutics Holdings Inc
Total Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Total Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Arcturus Therapeutics Holdings Inc
NASDAQ:ARCT
|
Total Assets
$418.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
57%
|
CAGR 10-Years
25%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Total Assets
$148.9B
|
CAGR 3-Years
0%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Assets
$56.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
7%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Assets
$93B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
3%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Assets
$23.9B
|
CAGR 3-Years
25%
|
CAGR 5-Years
30%
|
CAGR 10-Years
27%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Assets
$34.4B
|
CAGR 3-Years
25%
|
CAGR 5-Years
22%
|
CAGR 10-Years
27%
|
See Also
What is Arcturus Therapeutics Holdings Inc's Total Assets?
Total Assets
418.8m
USD
418.8m
USD
Based on the financial report for Mar 31, 2024, Arcturus Therapeutics Holdings Inc's Total Assets amounts to 418.8m USD.
What is Arcturus Therapeutics Holdings Inc's Total Assets growth rate?
Total Assets CAGR 10Y
25%
25%
Over the last year, the Total Assets growth was -11%. The average annual Total Assets growth rates for Arcturus Therapeutics Holdings Inc have been -5% over the past three years , 57% over the past five years , and 25% over the past ten years .
You don't have any saved screeners yet
